Study for efficacy and safety of robot-assisted thoracoscopic lung resection for lung cancer patients using da Vinci surgical system

Study for efficacy and safety of robot-assisted thoracoscopic lung resection for lung cancer patients using da Vinci surgical system - Efficacy and safety of robot-assisted thoracoscopic lung resection for lung cancer patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022176

Enrollment

Registered

2016-05-09

Start date

2016-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Lung resection for lung cancer patients will be performed by robot-assisted thoracoscopic surgery using da Vinci surgical system.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lung cancer patients (including suspected) diagnosed by CT scan and other examinations Clinical stage I (cT1aN0M0 or cT1bN0M0) Informed consent obtained from the patient

Exclusion criteria

Exclusion criteria: Severe cardiac disorders Severe pulmonary disorders Impossible cessation of anticoagulants Severe obesity (BMI>35) Patients without informed consent Any other reasons considered as inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Operative time, blood loss, perioperative complications, histopathological findings, and postoperative outcome	—

Countries

Japan

Contacts

Public ContactHisashi Suzuki

Ibaraki Prefectural Central Hospital Department of Thoracic Surgery

hsuzuki-jpn@umin.ac.jp0296-77-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026